Related references
Note: Only part of the references are listed.A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with 131I-refractory differentiated thyroid cancer (SELECT).
Martin Schlumberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target
Jiancheng Zhou et al.
CANCER LETTERS (2016)
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Hayley J. Sharpe et al.
CANCER CELL (2015)
p53 modulates the activity of the GLI1 oncogene through interactions with the shared coactivator TAF9
Joon Won Yoon et al.
DNA REPAIR (2015)
MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
Lucile Hoch et al.
FASEB JOURNAL (2015)
SOX9 inhibits β-TrCP-mediated protein degradation to promote nuclear GLI1 expression and cancer stem cell properties
Wentao Deng et al.
JOURNAL OF CELL SCIENCE (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
GLI2 inhibition abrogates human leukemia stem cell dormancy
Anil Sadarangani et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells
Armine Matevossian et al.
MOLECULAR CANCER (2015)
The gain-of-function GLI1 transcription factor TGLI1 enhances expression of VEGF-C and TEM7 to promote glioblastoma angiogenesis
Richard L. Carpenter et al.
ONCOTARGET (2015)
Heparanase mediates a novel mechanism in lapatinib-resistant brain metastatic breast cancer
Lixin Zhang et al.
NEOPLASIA (2015)
Darinaparsin Inhibits Prostate Tumor-Initiating Cells and Du145 Xenografts and Is an Inhibitor of Hedgehog Signaling
Nitu Bansal et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Sabrina Pricl et al.
MOLECULAR ONCOLOGY (2015)
Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway
Zhang Ke et al.
MEDICAL ONCOLOGY (2015)
Hedgehog acyltransferase as a target in pancreatic ductal adenocarcinoma
E. Petrova et al.
ONCOGENE (2015)
The potential of heparanase as a therapeutic target in cancer
Claudio Pisano et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
C. D'Amato et al.
BRITISH JOURNAL OF CANCER (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
The GLI1 splice variant TGLI1 promotes glioblastoma angiogenesis and growth
Hu Zhu et al.
CANCER LETTERS (2014)
Bevacizumab: A Review of Its Use in Advanced Cancer
Gillian M. Keating
DRUGS (2014)
Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
Tsuyoshi Ishii et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1
Kornelius Kerl et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The Transcription Factor GLI1 Interacts with SMAD Proteins to Modulate Transforming Growth Factor β-Induced Gene Expression in a p300/CREB-binding Protein-associated Factor (PCAF)-dependent Manner
Monica D. Nye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Hedgehog pathway as a potential treatment target in human cholangiocarcinoma
Dorothee Riedlinger et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Targeting of the Hedgehog signal transduction pathway suppresses survival of malignant pleural mesothelioma cells in vitro
Min You et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
Edward B. Garon et al.
LANCET (2014)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose et al.
LANCET (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Down-Regulation of Gli Transcription Factor Leads to the Inhibition of Migration and Invasion of Ovarian Cancer Cells via Integrin β4-Mediated FAK Signaling
Qi Chen et al.
PLOS ONE (2014)
Blocking Signaling at the Level of GLI Regulates Downstream Gene Expression and Inhibits Proliferation of Canine Osteosarcoma Cells
Mehdi Hayat Shahi et al.
PLOS ONE (2014)
Context-dependent signal integration by the GLI code: The oncogenic load, pathways, modifiers and implications for cancer therapy
Fritz Aberger et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
Chun-Jen Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
Ritesh K. Srivastava et al.
ONCOTARGET (2014)
Antitumor Activity of Lenvatinib (E7080): An Angiogenesis Inhibitor That Targets Multiple Receptor Tyrosine Kinases in Preclinical Human Thyroid Cancer Models
Osamu Tohyama et al.
JOURNAL OF THYROID RESEARCH (2014)
Arsenic Trioxide Inhibits the Hedgehog Pathway Which Is Aberrantly Activated in Acute Promyelocytic Leukemia
Dongguang Yang et al.
ACTA HAEMATOLOGICA (2013)
Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
A. V. Salnikov et al.
BRITISH JOURNAL OF CANCER (2013)
Smoothened Inhibition Leads to Decreased Proliferation and Induces Apoptosis in Esophageal Adenocarcinoma Cells
Ali H. Zaidi et al.
CANCER INVESTIGATION (2013)
A Novel Model for Evaluating Therapies Targeting Human Tumor Vasculature and Human Cancer Stem-like Cells
Daniela Burgos-Ojeda et al.
CANCER RESEARCH (2013)
Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo
Malin Wickstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition
Qing Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
TAK-441, a novel investigational smoothened antagonist, delays castration-resistant progression in prostate cancer by disrupting paracrine hedgehog signaling
Naokazu Ibuki et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Cabozantinib in Progressive Medullary Thyroid Cancer
Rossella Elisei et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer
Katherine T. Ostapoff et al.
MOLECULAR CANCER THERAPEUTICS (2013)
A phase I study determining the safety and tolerability of combination therapy with Pazopanib (P), a VEGFR/PDGFR/Raf inhibitor, and GSK1120212 (Trametinib: T), a MEK inhibitor, in advanced solid tumors with expansion cohorts in advanced differentiated thyroid cancer (DTC), cholangiocarcinoma (ChCA), and soft tissue sarcoma (STS).
Nilofer Azad et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial
George D. Demetri et al.
LANCET (2013)
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
Axel Grothey et al.
LANCET (2013)
Structure of the human smoothened receptor bound to an antitumour agent
Chong Wang et al.
NATURE (2013)
Inhibitors of Hedgehog acyltransferase block Sonic Hedgehog signaling
Elissaveta Petrova et al.
NATURE CHEMICAL BIOLOGY (2013)
NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200
Junsheng Fu et al.
NEURO-ONCOLOGY (2013)
Arsenic Trioxide Prevents Osteosarcoma Growth by Inhibition of GLI Transcription via DNA Damage Accumulation
Shunsuke Nakamura et al.
PLOS ONE (2013)
Arsenic trioxide inhibits viability of pancreatic cancer stem cells in culture and in a xenograft model via binding to SHH-Gli
Jin-bin Han et al.
ONCOTARGETS AND THERAPY (2013)
Axitinib for the Management of Metastatic Renal Cell Carcinoma
Bernard Escudier et al.
Drugs in research & development (2013)
NVP-LDE-225 (Erismodegib) inhibits epithelial-mesenchymal transition and human prostate cancer stem cell growth in NOD/SCID IL2Rγ null mice by regulating Bmi-1 and microRNA-128
R. Nanta et al.
ONCOGENESIS (2013)
Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
Marine Gross-Goupil et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2013)
Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice
Akifumi Kogame et al.
DRUG METABOLISM AND DISPOSITION (2013)
Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility
Tomohiro Ohashi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
Basel Sitohy et al.
CANCER RESEARCH (2012)
Hedgehog Signaling Is a Novel Therapeutic Target in Tamoxifen-Resistant Breast Cancer Aberrantly Activated by PI3K/AKT Pathway
Bhuvaneswari Ramaswamy et al.
CANCER RESEARCH (2012)
Vandetanib, an Inhibitor of VEGF Receptor-2 and EGF Receptor, Suppresses Tumor Development and Improves Prognosis of Liver Cancer in Mice
Kinya Inoue et al.
CLINICAL CANCER RESEARCH (2012)
Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells
Nadine Andrae et al.
EUROPEAN JOURNAL OF CANCER (2012)
Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin
Eri Makinodan et al.
EXPERIMENTAL DERMATOLOGY (2012)
Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis
Vito Ferro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Effective Targeting of Hedgehog Signaling in a Medulloblastoma Model with PF-5274857, a Potent and Selective Smoothened Antagonist That Penetrates the Blood-Brain Barrier
Allison Rohner et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
Winette T. A. van der Graaf et al.
LANCET (2012)
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Aleksandar Sekulic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells
X. Cao et al.
ONCOGENE (2012)
The activity of Gli transcription factors is essential for Kras-induced pancreatic tumorigenesis
Mihir Rajurkar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
Michael J. Munchhof et al.
ACS MEDICINAL CHEMISTRY LETTERS (2012)
The VEGF Pathway in Cancer and Disease: Responses, Resistance, and the Path Forward
Mark W. Kieran et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Gli Proteins in Development and Disease
Chi-chung Hui et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 27 (2011)
Identification and characterization of a novel smoothened antagonist for the treatment of cancer with deregulated hedgehog signaling
Mark H. Bender et al.
CANCER RESEARCH (2011)
Direct targeting of the Hedgehog pathway in primary chondrosarcoma xenografts with the Smoothened inhibitor IPI-926
Veronica Travaglione Campbell et al.
CANCER RESEARCH (2011)
The novel therapeutic monoclonal antibody VGX-100 neutralises VEGF-C and inhibits tumor growth and metastasis in subcutaneous and orthotopic models of human cancer.
Megan E. Baldwin et al.
CANCER RESEARCH (2011)
Hedgehog Fights Back: Mechanisms of Acquired Resistance against Smoothened Antagonists
Ciara Metcalfe et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Targeting Superficial or Nodular Basal Cell Carcinoma with Topically Formulated Small Molecule Inhibitor of Smoothened
Tracy Tang et al.
CLINICAL CANCER RESEARCH (2011)
Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
Scott M. Wilhelm et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway
Elspeth M. Beauchamp et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cabozantinib (XL184), a Novel MET and VEGFR2 Inhibitor, Simultaneously Suppresses Metastasis, Angiogenesis, and Tumor Growth
F. Michael Yakes et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Once on 'Fast Track,' Avastin Now Derailed
Jennifer Couzin-Frankel et al.
SCIENCE (2011)
Tumor shrinkage by cyclopamine tartrate through inhibiting hedgehog signaling
Qipeng Fan et al.
Chinese Journal of Cancer (2011)
The Hedgehog's tale: developing strategies for targeting cancer
Jessica M. Y. Ng et al.
NATURE REVIEWS CANCER (2011)
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Cora N. Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma
Zeshaan A. Rasheed et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Smoothened as a new therapeutic target for human osteosarcoma
Masataka Hirotsu et al.
MOLECULAR CANCER (2010)
Cytotoxic Effects Induced by Docetaxel, Gefitinib, and Cyclopamine on Side Population and Nonside Population Cell Fractions from Human Invasive Prostate Cancer Cells
Murielle Mimeault et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Molecular Therapy Targeting Sonic Hedgehog and Hepatocyte Growth Factor Signaling in a Mouse Model of Medulloblastoma
Valerie Coon et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Context-dependent Regulation of the GLI Code in Cancer by HEDGEHOG and Non-HEDGEHOG Signals
Barbara Stecca et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2010)
Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
Shifeng Pan et al.
ACS MEDICINAL CHEMISTRY LETTERS (2010)
GDC-0449-A potent inhibitor of the hedgehog pathway
Kirk D. Robarge et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
Hui-Wen Lo et al.
CANCER RESEARCH (2009)
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Barbara Stecca et al.
EMBO JOURNAL (2009)
Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
Frederic Varnat et al.
EMBO MOLECULAR MEDICINE (2009)
Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma
Robert J. Motzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Martin R. Tremblay et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Preclinical characterization of BMS-833923 (XL139), a hedgehog (HH) pathway inhibitor in early clinical development
Steven B. Gendreau et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Regulation of the Hedgehog Signaling by the Mitogen-Activated Protein Kinase Cascade in Gastric Cancer
Motoko Seto et al.
MOLECULAR CARCINOGENESIS (2009)
Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
Chen Zhao et al.
NATURE (2009)
Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.
Charles M. Rudin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Smoothened Adopts Multiple Active and Inactive Conformations Capable of Trafficking to the Primary Cilium
Christopher W. Wilson et al.
PLOS ONE (2009)
Gli2 trafficking links Hedgehog-dependent activation of Smoothened in the primary cilium to transcriptional activation in the nucleus
Jynho Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Robert L. Yauch et al.
SCIENCE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
Suzie J. Scales et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Targeted inhibition of hedgehog signaling by cyclopamine prodrugs for advanced prostate cancer
Srinivas K. Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Synthesis and anticancer activity studies of cyclopamine derivatives
Jianjun Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation
Christine Dierks et al.
CANCER CELL (2008)
Targeting CD24 for treatment of colorectal and pancreatic cancer by monoclonal antibodies or small interfering RNA
Eyal Sagiv et al.
CANCER RESEARCH (2008)
Hedgehog: functions and mechanisms
Markku Varjosalo et al.
GENES & DEVELOPMENT (2008)
Hhat is a palmitoylacyltransferase with specificity for N-palmitoylation of Sonic Hedgehog
John A. Buglino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
A paracrine requirement for hedgehog signalling in cancer
Robert L. Yauch et al.
NATURE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Marcel Kool et al.
PLOS ONE (2008)
Basal cell carcinomas: attack of the hedgehog
Ervin H. Epstein
NATURE REVIEWS CANCER (2008)
Hedgehog regulates smoothened activity by inducing a conformational switch
Yun Zhao et al.
NATURE (2007)
PI-88 and novel heparan sulfate mimetics inhibit angiogenesis
Vito Ferro et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2007)
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Matthias Lauth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Melanomas require HEDGEHOG-GLI signaling reaulated by interactions between GLI1 and the RAS-MEK/AKT pathways
Barbara Stecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: A new paradigm for combination therapy in solid cancers
Georg Feldmann et al.
CANCER RESEARCH (2007)
Frequent requirement of hedgehog signaling in non-small cell lung carcinoma
Z. Yuan et al.
ONCOGENE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma
Eli E. Bar et al.
STEM CELLS (2007)
Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies
Ted Shih et al.
CLINICAL THERAPEUTICS (2006)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
Suling Liu et al.
CANCER RESEARCH (2006)
Regulation of Gli1 localization by the cAMP/protein kinase A signaling axis through a site near the nuclear localization signal
T Sheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice
P Sanchez et al.
MECHANISMS OF DEVELOPMENT (2005)
Palmitoylation is required for the production of a soluble multimeric Hedgehog protein complex and long-range signaling in vertebrates
MH Chen et al.
GENES & DEVELOPMENT (2004)
Distinct roles of PTCH2 splice variants in Hedgehog signalling
F Rahnama et al.
BIOCHEMICAL JOURNAL (2004)
The negative regulator of Gli, Suppressor of fused (Sufu), interacts with SAP18, Galectin3 and other nuclear proteins
M Paces-Fessy et al.
BIOCHEMICAL JOURNAL (2004)
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
M Kubo et al.
CANCER RESEARCH (2004)
Inhibition of prostate cancer proliferation by interference with SONICHEDGEHOG-GLI1 signaling
P Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The Hedgehog response network: Sensors, switches, and routers
L Lum et al.
SCIENCE (2004)
Novel lipid modifications of secreted protein signals
RK Mann et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2004)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
SS Karhadkar et al.
NATURE (2004)
Glycoalkaloids and metabolites inhibit the growth of human colon (HT29) and liver (HepG2) cancer cells
KR Lee et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
SP Thayer et al.
NATURE (2003)
Combined activities of hedgehog signaling inhibitors regulate pancreas development
H Kawahira et al.
DEVELOPMENT (2003)
Opportunities for Trisenox® (arsenic trioxide) in the treatment of myelodysplastic syndromes
A List et al.
LEUKEMIA (2003)
Identification of a small molecule inhibitor of the hedgehog signaling pathway: Effects on basal cell carcinoma-like lesions
JA Williams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
DN Watkins et al.
NATURE (2003)
Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened
JK Chen et al.
GENES & DEVELOPMENT (2002)
Regulation of Gli1 transcriptional activity in the nucleus by Dyrk1
JH Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Medulloblastoma growth inhibition by Hedgehog pathway blockade
DM Berman et al.
SCIENCE (2002)
Desert Hedgehog/Patched 1 signaling specifies fetal Leydig cell fate in testis organogenesis
HHC Yao et al.
GENES & DEVELOPMENT (2002)
Suppressor of Fused represses Gli-mediated transcription by recruiting the SAP18-mSin3 corepressor complex
SY Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of a sonic hedgehog signal transducer, hedgehog-interacting protein, by human basal cell carcinoma
M Tojo et al.
BRITISH JOURNAL OF DERMATOLOGY (2002)
Hedgehog signaling in animal development: paradigms and principles
PW Ingham et al.
GENES & DEVELOPMENT (2001)
Comparative biological responses to human Sonic, Indian, and Desert hedgehog
S Pathi et al.
MECHANISMS OF DEVELOPMENT (2001)
Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine
J Taipale et al.
NATURE (2000)
Share Paper
